Logo

OpiCalc

FavoritesSpecialtiesDrugsGuidelinesMost Used

Quick Access

Favorites
Most Used

All Specialties

OpiCalc Logo
Clinical CalculatorsDrugsGuidelines
SpecsDrugsGuides
Bethesda System (Thyroid FNA)Breslow Depth (Melanoma)Calculated Serum OsmolalityCorrected Calcium (Albumin)Corrected Sodium (Hyperglycaemia)Delta-Delta RatioFractional Excretion of Sodium (FENa)Fractional Excretion of Urea (FEUrea)Partin Tables (Prostate Cancer)Serum Anion Gap
OpiCalc Logo

OpiCalc

Easy, fast, and private medical tools for clinicians. Always free.

No Login Required
Ready for the Bedside

Resources

About UsEditorial PolicyMedical DisclaimerPrivacy PolicyTerms of UseCookie Policy

Support

Contact Us

Clinical Notice:OpiCalc is not a substitute for professional clinical judgment. Always verify dosages and guidelines.

OpiCalc © 2026

•

All Rights Reserved

Specialty Module

Pathology

Precision diagnostic classification, lab-based clinical metrics, and malignancy staging aids.

10

Clinical Tools

6

Clinical Domains

13

Conditions Covered

5

Guidelines Referenced

Clinical Context

Acid-base disorder interpretation tools

Acid-base disorder interpretation requires systematic assessment of pH, PaCO2, and HCO3 using the anion gap, delta-delta ratio, and Winter's formula. These tools differentiate simple from mixed acid-base disorders, identify the primary disturbance, and determine appropriate compensation, guiding life-saving interventions in critically ill patients.

Thyroid cytopathology with Bethesda classification

Thyroid cytopathology reporting follows The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC), which categorizes FNA results into six diagnostic categories (I-VI) with implied malignancy risks ranging from 0-3% (Benign) to nearly 100% (Malignant). These categories guide clinical management from clinical follow-up to total thyroidectomy with lymph node dissection.

Melanoma and prostate cancer prognostic nomograms

Cutaneous melanoma prognosis is determined by Breslow thickness (vertical tumor invasion measured in millimeters), the most powerful predictor of survival. The Partin tables predict pathological stage at radical prostatectomy based on preoperative PSA, clinical T-stage, and biopsy Gleason score, guiding decisions between radical prostatectomy, radiation therapy, and active surveillance.

Conditions & Domains

Clinical Conditions Covered

Metabolic Acidosis
Metabolic Alkalosis
Respiratory Acidosis
Respiratory Alkalosis
Mixed Acid-Base Disorders
Thyroid Nodules
Thyroid Cancer
Melanoma
Prostate Cancer
Acute Kidney Injury
Toxic Alcohol Ingestion
Diabetic Ketoacidosis
Hypercalcemia

Evidence Base

Referenced Guidelines & Standards

Bethesda System for Thyroid Cytopathology (3rd Edition)
AJCC Melanoma Staging 8th Edition
CAP Cancer Reporting Protocols
ACMG Laboratory Standards
CLSI Guidelines

Toolkit

10 Clinical Calculators

Peer-Reviewed
Bethesda System (Thyroid FNA)
Breslow Depth (Melanoma)
Calculated Serum Osmolality
Corrected Calcium (Albumin)
Corrected Sodium (Hyperglycaemia)
Delta-Delta Ratio
Fractional Excretion of Sodium (FENa)
Fractional Excretion of Urea (FEUrea)
Partin Tables (Prostate Cancer)
Serum Anion Gap

About

Pathology

The Pathology and Laboratory Medicine hub provides clinician-validated tools for interpreting complex diagnostic data. From serum electrolyte deviations and acid-base modeling to standardized malignancy reporting and urologic staging nomograms, our suite transforms raw laboratory results into actionable clinical insights.

Covered Areas

  • Acid-Base & Electrolyte Modeling
  • Thyroid Cytopathology
  • Dermatopathologic Staging
  • Urologic Prognostic Nomograms
  • Acute Kidney Injury Differential
  • Toxicology Screening

All tools are based on published clinical evidence. Results should be interpreted alongside individual patient presentation and current institutional guidelines.